What Can Providers Give to Patients, Part 4

by Elizabeth E. Hogue, Esq.

What Can Providers Give to Patients...

...and COVID-19

On May 24, 2021, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services (HHS) issued another FAQ on the Application of Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease:

Would the offer or provision of cash, cash-equivalent, or in-kind incentives or rewards to Federal health care program beneficiaries who receive COVID-19 vaccinations during the public health emergency violate the OIG’s administrative enforcement authorities?

Covid Vaccine Incentives

The OIG first addressed this question by acknowledging that a broad range of entities, including providers, are offering a wide variety of incentives and rewards to recipients who are vaccinated; such as food and beverages, cash, and tickets to concerts and sporting events. The OIG recognizes that widespread vaccine administration is crucial to the pandemic response and that incentives and rewards may promote broader access and increase the number of recipients.

A question of legality

The OIG also pointed out, however, that these rewards and incentives may violate the federal Anti-Kickback Statute (AKS) and the Civil Monetary Penalties Law (CMPL) governing beneficiary inducements.

An Exception to the Rule

The OIG then concluded that providers, in the limited context of the COVID-19 public health emergency, may give rewards or incentives to beneficiaries who receive either one or both doses of the vaccine because such incentives and rewards “would be sufficiently low risk under the Federal anti-kickback statute and Beneficiary Inducements CMP.” 

With Limitations

Providers must, however, meet the following requirements:

Providers Patients COVID
The incentive or reward must be furnished in connection with receipt of a required dose of COVID-19 vaccine, including either one or two doses depending on vaccine type.

The vaccine administered is authorized or approved by the Food and Drug Administration (FDA) as a vaccine for COVID-19 and is administered in compliance with all other applicable federal and state rules and regulations, including conditions for receipt of vaccine supplies from the federal government by providers.

Incentives or rewards are not tied to or contingent upon any other arrangement or agreement offering incentives or rewards between providers and beneficiaries.

Incentives or rewards are not conditioned on recipients’ past or anticipated future use of other items or services that are reimbursable in whole or in part by federal health care programs.

Incentives or rewards are provided during the COVID-19 public health emergency.

Does Not Apply

The OIG then pointed out that the AKS and CMPL relate to items and services for which payment may be made in whole or in part under a Federal health program. According to the OIG, it is unlikely that these statutes are implicated by incentive and rewards furnished to commercially insured or uninsured individuals.

Not Specific to Covid

Finally, the OIG concluded by saying that it would not express any opinion on the merits or utility of particular incentives or rewards to address the goal of encouraging vaccination. 

As long as the criteria above are met, providers may give incentives or rewards to beneficiaries in order to encourage them to be vaccinated.

This article is part 4 in the series. Read Part 1, Part 2, and Part 3.

# # #

Elizabeth E. Hogue, Esq.
Elizabeth E. Hogue, Esq.

Elizabeth Hogue is an attorney in private practice with extensive experience in health care. She represents clients across the U.S., including professional associations, managed care providers, hospitals, long-term care facilities, home health agencies, durable medical equipment companies, and hospices.

©2025 Elizabeth E. Hogue, Esq. All rights reserved.

No portion of this material may be reproduced in any form without the advance written permission of the author.

©2025 by The Rowan Report, Peoria, AZ. All rights reserved. 

New COVID Evidence Changes the Way Healthcare is Delivered

New COVID Evidence Changes the Way Healthcare is Delivered

by Tim Rowan, Editor

In its August 12 edition, Smithsonian Magazine summarized new research conducted by epidemiologists and published both in The New England Journal of Medicine and a bulletin of the Centers for Disease Control and Prevention. What these scientists have discovered may have an impact on the way in-home clinicians, therapists, and other caregivers practice.

The report reveals findings that not only larger droplets but also microscopic aerosols can transmit the novel coronavirus that causes COVID-19. In fact, aerosols – measuring one-tenth the width of a human hair – can linger suspended in the air for hours. Droplets, which are expelled by sneezing or coughing, are much larger and fall to the ground or other surfaces much more quickly.

“While the difference is literally miniscule,” the report acknowledges, “knowledge of this route of transmission would result in significant changes in how the public can bring an end to the global pandemic. In the near term, it would inform social distancing and mask wearing recommendations from local governments, and in the long term, engineers and architects will need to rethink ventilation and air filtration in the design of everything from schools to cruise ships.”

Aerosols carry pathogens up to dozens of meters under the right conditions. How long a virus can remain airborne depends on the size of the droplet containing it. “That determines everything about how far it can travel, how long it can stay airborne before it falls to the ground,” says Linsey Marr, a professor of civil and environmental engineering at Virginia Tech.

While suspended in the air for hours, some experiments have shown it is possible for the aerosols to remain contagious “for many hours.” says Marr. Different experiments have produced widely varying results, from “more than an hour” in the NEJM report, to “up to 16 hours,” according to CDC researchers.

New discoveries underscore need for familiar prevention activities

  1. Hand-washing kills aerosols that are picked up while suspended in the air.
  2. Masks block aerosol sprays to varying degrees depending on the type of mask worn.
  3. Social distancing remains important because the concentration of aerosols is heaviest near an infected person.

The Smithsonian report concludes that airborne transmission of microscopic aerosols raises the issue of how to protect workers in healthcare settings. When PPE and respirators are in short supply, they should go to healthcare workers first. Surgical masks offer some protection, but it may not be enough for workers who routinely interact with the public. When an in-home care worker enters a patient’s home, they should be aware of the possibility of airborne aerosols and affix their mask well before someone answers the door. The cough that happened an hour before their arrival could be as dangerous as the one that happens while they are in the home.

Read the entire Smithsonian report here.

©2020 by Rowan Consulting Associates, Inc., Colorado Springs, CO. All rights reserved. This article originally appeared in Home Care Technology: The Rowan Report. homecaretechreport.com One copy may be printed for personal use; further reproduction by permission only. editor@homecaretechreport.com